All In MedTech

FDA Clearance Tracker · P080020-S020

GEL-ONE(R)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 27, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P080020-S020
Device name
GEL-ONE(R)
Applicant location
Tokyo
Received
Apr 1, 2016
Decided
Sep 27, 2016
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P080020

Device type

Device class
Class III

Every decision under product code MOZ

FDA's approval statement

As written in FDA's record.

Approval for Gel-One. The device is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to non-pharmacologic therapy, non-steroidal anti-inflammatory drugs (NSAIDs) or analgesics, e.g., acetaminophen.

Source documents

Other decisions for Seikagaku Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.